At close: 3:59:49 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 2 |
| Avg. Estimate | 0 | 0 | -0.66 | -0.48 |
| Low Estimate | 0 | 0 | -0.66 | -0.59 |
| High Estimate | 0 | 0 | -0.66 | -0.37 |
| Year Ago EPS | -- | -- | -0.73 | -0.66 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -- | -0.14 | -0.13 |
| EPS Actual | -0.16 | -0.14 | -0.28 | -0.14 |
| Difference | 0 | -- | -0.14 | -0.01 |
| Surprise % | 0.00% | -- | -100.00% | -7.69% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.66 | -0.48 |
| 7 Days Ago | 0 | 0 | -0.75 | -0.48 |
| 30 Days Ago | 0 | 0 | -0.66 | -0.37 |
| 60 Days Ago | 0 | 0 | -0.66 | -0.37 |
| 90 Days Ago | 0 | 0 | -0.94 | -0.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVM | -- | -- | 9.59% | 27.27% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy to Buy | 7/12/2023 |
| Reiterates | EF Hutton: Buy | 3/9/2023 |
| Maintains | EF Hutton: Buy | 12/29/2022 |
| Initiated | EF Hutton: Buy | 4/7/2022 |
| Initiated | HC Wainwright & Co.: Buy | 1/13/2020 |
| Initiated | Taglich Brothers: Speculative Buy | 2/20/2013 |
Related Tickers
IMMX Immix Biopharma, Inc.
2.1000
-6.67%
NWBO Northwest Biotherapeutics, Inc.
0.2660
-0.23%
MTNB Matinas BioPharma Holdings, Inc.
0.6251
-5.86%
SYRS Syros Pharmaceuticals, Inc.
0.2250
+7.14%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
CTXR Citius Pharmaceuticals, Inc.
3.6300
-2.16%
CDIO Cardio Diagnostics Holdings, Inc.
0.6710
-8.11%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
VRPX Virpax Pharmaceuticals, Inc.
0.3690
+0.93%
NKGN NKGen Biotech, Inc.
0.4890
-14.59%